The Transcription Factor CREB1 Triggers the Progression of Clear Cell Renal Cell Carcinoma by Promoting CENPE Expression
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Hao Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China. Hauptthemen laut MEDLINE: Cyclic AMP Response Element-Binding Protein, Carcinoma, Renal Cell, Gene Expression Regulation, Neoplastic, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key R&D Program of Jiangsu Province, The Suzhou Gusu Medical Youth Talent, Gusu Medical Talent Foundation.
Abstract (Originalsprache)
Centromere‐associated protein E (CENPE) has been identified as overexpressed in multiple cancers and exerts a tumour promotion function by affecting chromosome misalignment and mitosis. However, the expression pattern, biological roles, and underlying molecular mechanism of CENPE in clear cell renal cell carcinoma (ccRCC) progression have not been fully elucidated. In the present study, the expression levels of CENPE in ccRCC and paracancerous specimens were measured using the public RNA sequencing data and validated in a cohort of ccRCC samples from our centre. We found that CENPE was significantly over‐expressed in ccRCC tissues and promoted proliferative and metastatic abilities of ccRCC cells and xenografts through regulating the epithelial‐mesenchymal transition (EMT) process. Furthermore, bioinformatic analysis and ChIP assay indicated that the transcription factor CREB1 bound to the promoter region of CENPE and activated its transcription in ccRCC cells. Taken together, our findings demonstrated that the CREB1‐CENPE axis was responsible for stimulating the in vitro and in vivo progression of ccRCC, serving as a promising therapeutic target for ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
- Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
- Department of Urology, Suzhou Ninth People's Hospital, Soochow University, Suzhou, People's Republic of China.
- Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, Texas, USA.
ORCID-Profile: Hao Jiang, Zhijun Cao, Yuhua Huang
Förderung
- the Key R&D Program of Jiangsu Province
- The Suzhou Gusu Medical Youth Talent
- Gusu Medical Talent Foundation
- Jiangsu Innovative and Entrepreneurial Talent Programme
- Bethune Medical Science Research Foundation
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Jiang, H., Tang, J., Cao, Z., Qiu, F., Chai, Z., Qi, J., Zhou, F., & Huang, Y. (2025). The Transcription Factor CREB1 Triggers the Progression of Clear Cell Renal Cell Carcinoma by Promoting CENPE Expression. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70773
Vancouver
Jiang H, Tang J, Cao Z, Qiu F, Chai Z, Qi J, et al. The Transcription Factor CREB1 Triggers the Progression of Clear Cell Renal Cell Carcinoma by Promoting CENPE Expression. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70773
BibTeX
@article{Jiang2025,
author = {Jiang, Hao and Tang, Jingyuan and Cao, Zhijun and Qiu, Feng and Chai, Zhuodong and Qi, Jiaqian and Zhou, Feng and Huang, Yuhua},
title = {The Transcription Factor CREB1 Triggers the Progression of Clear Cell Renal Cell Carcinoma by Promoting CENPE Expression},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70773}
}
EUVIMED